Display options
Share it on

J Clin Med. 2019 Jun 05;8(6). doi: 10.3390/jcm8060807.

Safety and Efficacy of Medical Cannabis in Fibromyalgia.

Journal of clinical medicine

Iftach Sagy, Lihi Bar-Lev Schleider, Mahmoud Abu-Shakra, Victor Novack

Affiliations

  1. Department of Rheumatology, Rabin Medical Center, Petach Tikva 49100, Israel. [email protected].
  2. Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva 84101, Israel. [email protected].
  3. Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva 84101, Israel. [email protected].
  4. Research Department, Tikun Olam LTD, Tel-Aviv 6296602, Israel. [email protected].
  5. Department of Rheumatology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva 84101, Israel. [email protected].
  6. Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva 84101, Israel. [email protected].

PMID: 31195754 PMCID: PMC6616435 DOI: 10.3390/jcm8060807

Abstract

BACKGROUND: Chronic pain may be treated by medical cannabis. Yet, there is scarce evidence to support the role of medical cannabis in the treatment of fibromyalgia. The aim of the study was to investigate the characteristics, safety, and effectiveness of medical cannabis therapy for fibromyalgia.

METHODS: A prospective observational study with six months follow-up period based on fibromyalgia patients who were willing to answer questionnaire in a specialized medical cannabis clinic between 2015 and 2017.

RESULTS: Among the 367 fibromyalgia patients, the mean age was 52.9 ± 15.1, of whom 301 (82.0%) were women. Twenty eight patients (7.6%) stopped the treatment prior to the six months follow-up. The six months response rate was 70.8%. Pain intensity (scale 0-10) reduced from a median of 9.0 at baseline to 5.0 (

CONCLUSION: Medical cannabis appears to be a safe and effective alternative for the treatment of fibromyalgia symptoms. Standardization of treatment compounds and regimens are required.

Keywords: chronic pain; fibromyalgia; medical cannabis; quality of life

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. J Addict Dis. 2000;19(3):89-103 - PubMed
  2. Ann Intern Med. 2001 May 1;134(9 Pt 2):868-81 - PubMed
  3. Pharmacol Rev. 2006 Sep;58(3):389-462 - PubMed
  4. J Pain. 2008 Feb;9(2):164-73 - PubMed
  5. Pain Physician. 2008 Mar;11(2 Suppl):S105-20 - PubMed
  6. CMAJ. 2008 Jun 17;178(13):1669-78 - PubMed
  7. Anesth Analg. 2010 Feb 1;110(2):604-10 - PubMed
  8. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10 - PubMed
  9. PLoS One. 2011 Apr 21;6(4):e18440 - PubMed
  10. Arthritis Rheum. 2013 Feb;65(2):291-302 - PubMed
  11. Arthritis Care Res (Hoboken). 2013 May;65(5):786-92 - PubMed
  12. Pain Res Treat. 2013;2013:898493 - PubMed
  13. Eur J Clin Pharmacol. 2013 Aug;69(8):1575-80 - PubMed
  14. J Drug Policy Anal. 2011 Feb;4(1):null - PubMed
  15. Cochrane Database Syst Rev. 2014 Jan 03;(1):CD007115 - PubMed
  16. J Clin Oncol. 2014 Jun 1;32(16):1662-70 - PubMed
  17. Drug Alcohol Rev. 2015 Mar;34(2):141-6 - PubMed
  18. Arthritis Rheumatol. 2015 Feb;67(2):568-75 - PubMed
  19. PLoS One. 2015 Sep 17;10(9):e0138024 - PubMed
  20. J Pain. 2015 Dec;16(12):1233-1242 - PubMed
  21. Arthritis Care Res (Hoboken). 2016 May;68(5):681-8 - PubMed
  22. Ann Rheum Dis. 2017 Feb;76(2):318-328 - PubMed
  23. JAMA. 2016 Nov 1;316(17):1763-1764 - PubMed
  24. Gerontologist. 2017 Nov 10;57(6):1166-1172 - PubMed
  25. J Psychopharmacol. 2017 May;31(5):569-575 - PubMed
  26. J Pain Res. 2017 May 02;10:989-998 - PubMed
  27. Cannabis Cannabinoid Res. 2016 Jun 01;1(1):131-138 - PubMed
  28. JAMA Intern Med. 2018 Jan 1;178(1):9-10 - PubMed
  29. Eur J Intern Med. 2018 Mar;49:12-19 - PubMed
  30. Eur J Intern Med. 2018 Mar;49:44-50 - PubMed
  31. Eur J Intern Med. 2018 Mar;49:37-43 - PubMed
  32. Arthritis Rheum. 1995 Jan;38(1):19-28 - PubMed
  33. Arthritis Rheum. 1996 Nov;39(11):1852-9 - PubMed

Publication Types